GATA1 and erythroleukemia: In contrast, some mice with 95% reduced Gata1 mRNA expression due to a knockdown mutation (Gata1+/1.05) developed a late-onset B-cell lymphoproliferative disease or an earlier erythroleukemia-like disease5.